US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 74.860
  • -0.080-0.11%
Close Jul 19 16:00 ET
  • 73.410
  • -1.450-1.94%
Post 17:12 ET
7.90BMarket Cap-64534P/E (TTM)

Intra-Cellular Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intra-Cellular Therapies Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

144.87M

+52.00%
EPS(YoY)

-0.16

+65.22%
Analyst Rating

Strong Buy

Jul 19, 2024

Intra-Cellular Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 171.097M--
--2024/Q2-- / 158.191M--
May 7, 20242024/Q1144.866M / 141.444M--
Feb 22, 20242023/Q4132.099M / 135.668M--
Nov 2, 20232023/Q3126.173M / 119.228M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 171.097M--
--2024/Q2-- / 158.191M--
May 7, 20242024/Q1144.866M / 141.444M--
Feb 22, 20242023/Q4132.099M / 135.668M--
Nov 2, 20232023/Q3126.173M / 119.228M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies Earnings Reports

  • Intra-Cellular Therapies | 10-Q: Quarterly report

    May 7 07:44 ET

  • Intra-Cellular Therapies | 10-K: Annual report

    Feb 22 07:46 ET

  • Intra-Cellular Therapies | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 08:01 ET

  • Intra-Cellular Therapies | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 07:44 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 19, 2024

    Strong Buy

    • Buy

      84.62%

    • Hold

      15.39%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg